Putting the patient at the centre of clinical research

clinical research

Putting the patient at the centre of clinical research

The increasing use of RWD – Real World Data – is being driven by legislators, regulators and pricing bodies across the world. They are increasingly requiring companies and health systems to demonstrate the true real-world value and impact of their treatments, pathways, devices, and medications on patients.

This has meant that collecting patient-reported data and outcomes are becoming more and more important – and is driving clinical research to its moment of rapid digitisation. Just like what has happened in other industries – such as banking and commerce. Enabling patients to use their own smart device (Bring Your Own Device) and its built-in user interfaces, sensors, and connections to other devices will have a major impact for clinical data capture.

Benefits to the patient

Tracking one’s condition over time has been shown to improve a patient’s adherence to their medication, deepen their understanding of their condition and interestingly improve their perception of quality of their clinical consultations.

The benefits don’t end there when considering the use of data-tracking to support clinical research it allows for patients to be part of clinical trials with very low friction. They are using their own device, rather than going to a research site, reducing the amount of time they devote to research. They get the benefits of tracking and managing their conditions in return for providing their data for research. And by supporting clinical research, they are helping future patients with similar conditions.

Benefits to the industry

With the latest trial methods, the data gathered remotely is validated and secure from the moment the patient completes the survey or gives their input. Not only this but patients that are more engaged are statistically more likely to enter data over time. This is not to say this is instead of conventional methods but rather there is an opportunity to augment what is being done today.

What does this mean? It means with this sort of technology you could shorten research time horizons, start quicker and ending sooner than conventional methods. All while putting the patient at the centre of research.


Rupert Coghlan, Head of Insight, uMotif

Steph Meleck, Operational Account Manager, uMotif

Leave a Reply

Your email address will not be published. Required fields are marked *


blog archive